Literature DB >> 9526192

Acceptance of isoniazid preventive treatment by close contacts of tuberculosis cases: a 692-subject Italian study.

L R Codecasa1, G Besozzi.   

Abstract

SETTING: Villa Marelli Institute, Lombardy Regional Reference Centre for Tuberculosis.
OBJECTIVE: To evaluate acceptance of and adherence to isoniazid preventive treatment (IPT) of close contacts of contagious tuberculosis (TB) cases (CC); comparison of Italian and immigrant patients.
METHODS: A retrospective study of a consecutive series of 692 subjects (474 Italians and 218 immigrants from developing countries) exposed to contagious TB cases, who were offered IPT after tuberculin skin testing and chest X-ray, according to the Lombardy Regional Protocol for TB control.
RESULTS: Of 692 CCs, 36 (5.2%) subjects refused IPT, 522 (75.5%) completed the treatment as prescribed, 23 (3.3%) suspended IPT because of adverse effects, 14 (2.0%) spontaneously discontinued IPT against our advice, 93 (13.4%) were lost to follow up, and seven (0.6%) were still in treatment when the present data were evaluated. Italian CCs had a completion rate significantly higher than the immigrants (81.0% vs 63.3%, P < 0.01).
CONCLUSION: The rate of acceptance and completion of IPT in our population proved higher than many previously reported data, and the better results among Italian subjects reflect the importance of a complete comprehension of IPT that may not always be achieved with immigrant patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526192

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.

Authors:  Luigi Codecasa; Paola Mantegani; Laura Galli; Adriano Lazzarin; Paolo Scarpellini; Claudio Fortis
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.

Authors:  Paola Mantegani; Federica Piana; Luigi Codecasa; Laura Galli; Paolo Scarpellini; Adriano Lazzarin; Daniela Cirillo; Claudio Fortis
Journal:  Clin Med Res       Date:  2006-12

3.  Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.

Authors:  Claudia C Dobler; Guy B Marks
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

4.  Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy.

Authors:  Simone Villa; Maurizio Ferrarese; Giovanni Sotgiu; Paola Francesca Castellotti; Laura Saderi; Cecilia Grecchi; Matteo Saporiti; Mario Raviglione; Luigi Ruffo Codecasa
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.